Related Experiment Videos
Effects of a novel elastase inhibitor, ONO-5046, on nephrotoxic serum nephritis in rats
1Department of Clinical and Laboratory Medicine, Fukui Medical University, Japan. SSUZUKI@fmsrsa.fukui-med.ac.jp
Abstract:
ONO-5046 is a potent, specific and intravenously active inhibitor of neutrophil elastase. To examine the role of elastase in glomerulonephritis, we tested the effects of ONO-5046 on nephrotoxic serum (NTS) nephritis in a rat model of the disease in humans. Rats were administered ONO-5046 or phosphate-buffered saline (PBS) intraperitoneally 24 hours prior to injection of NTS, and they were then given equal doses of ONO-5046 or PBS three hours and 1, 2, 3, 4, 5 and 6 days later. Compared with the control groups, ONO-5046 significantly reduced proteinuria and hematuria, and suppressed the formation of crescentic glomeruli in a dose-dependent manner. Our results suggest that neutrophil elastase participates in NTS nephritis by degrading glomerular basement membrane proteins, and that the elastase inhibitor, ONO-5046, suppresses crescentic formation and glomerular injury caused by elastase.
Insights
ONO-5046, a neutrophil elastase inhibitor, significantly reduced proteinuria and hematuria in a rat model of glomerulonephritis. This suggests elastase plays a key role in kidney disease progression.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Neutrophil elastase is implicated in inflammatory kidney diseases.
- Glomerulonephritis involves damage to the glomerular basement membrane.
- Understanding elastase's role is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the therapeutic potential of ONO-5046, a neutrophil elastase inhibitor.
- To elucidate the role of neutrophil elastase in nephrotoxic serum (NTS) nephritis.
- To evaluate ONO-5046's efficacy in a rat model mimicking human glomerulonephritis.
Main Methods:
- Rats were induced with NTS nephritis and treated with ONO-5046 or PBS.
- ONO-5046 was administered intraperitoneally before and after NTS injection.
- Proteinuria, hematuria, and glomerular crescent formation were assessed.
Main Results:
- ONO-5046 significantly reduced proteinuria and hematuria compared to controls.
- The inhibitor suppressed the formation of crescentic glomeruli in a dose-dependent manner.
- These findings indicate ONO-5046's effectiveness in mitigating NTS nephritis.
Conclusions:
- Neutrophil elastase contributes to glomerular basement membrane degradation in NTS nephritis.
- ONO-5046, by inhibiting elastase, effectively suppresses crescent formation and glomerular injury.
- Targeting neutrophil elastase with inhibitors like ONO-5046 shows promise for treating glomerulonephritis.